HSP90:NSCLC

Yue Zhu1, Zhaoxia Dai1

  • 1Department of Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116021, Liaoning Province, China.

PubMed
概括

热冲击蛋白90 (HSP90) 是非小细胞肺癌 (NSCLC) 治疗的潜在目标. 对于特定的患者群体,HSP90抑制剂是有前途的,但毒性和有效性需要进一步的研究和优化.